Synergy Disc Reaches 100 U.S. Cases in 100 Days Following FDA Approval, Advancing Motion-Preserving Cervical Disc Replacement
Key Insights
The Synergy Disc (search) achieved 100 U.S. cervical disc replacement cases within 100 days of its first commercial procedure following FDA Premarket Approval earlier this year.
The device is the first artificial cervical disc designed to preserve motion while improving anatomic alignment with a unique 6-degree lordotic core and nickel-free titanium alloy (search).
U.S. IDE clinical trial data showed an 87.1% composite clinical success rate at 24 months, demonstrating superiority to anterior cervical discectomy and fusion (ACDF).
Synergy Spine Solutions (search) announced today that its Synergy Disc (search) has been used successfully in 100 cervical disc replacement surgeries in the United States, reaching the milestone within 100 days of the first commercial U.S. procedure following FDA approval earlier this year. The rapid adoption reflects growing surgeon demand for motion-preserving alternatives to traditional spinal fusion, with the device positioned as the first and only artificial cervical disc intentionally designed to preserve motion while improving anatomic alignment.
The Synergy Disc (search) features a unique 6-degree lordotic core engineered to restore the spine's natural curvature and is constructed from a nickel-free titanium alloy (search). This material choice addresses a significant clinical consideration: nickel allergy is among the most common metal allergies, with published estimates suggesting that up to 17% of women and 3% of men are allergic to nickel. The nickel-free composition may reduce a potential barrier for patients with nickel sensitivities or allergies.
"For years, our focus has been on preserving motion because that is fundamental to healthy cervical spine function," said Dr. Todd Lanman, a spinal neurosurgeon who participated in the Synergy Disc (search) 1-Level IDE trial and performed the first commercial Synergy Disc procedure in the United States. "As cervical disc replacement continues to evolve, we're also recognizing the importance of restoring cervical alignment. Synergy combines motion preservation with alignment restoration to better replicate the spine's natural biomechanics."
Clinical Evidence Supporting Superiority Over Fusion
The device received FDA Premarket Approval for 1-level indications at C3-C7 based on data from the company's U.S. Investigational Device Exemption study. Clinical results demonstrated that the Synergy Disc (search) achieved an 87.1% composite clinical success rate at 24 months, demonstrating superiority to anterior cervical discectomy and fusion (ACDF), the long-standing traditional treatment for cervical degenerative disc disease (search). Patients treated with the Synergy Disc also reported lower neck and arm pain scores and higher overall satisfaction compared to the ACDF control group.
"The clinical data behind the Synergy Disc (search) supports what is intuitive to surgeons: cervical disc replacement must preserve motion while also restoring alignment," said Neil Duggal, MD, Chief Medical Officer of Synergy Spine Solutions (search). "As more surgeons evaluate cervical disc replacement options, alignment is becoming a central part of the conversation."
Strong Surgeon Preference for Alignment Restoration
Across the first 100 procedures in the U.S., surgeons voluntarily selected the 6-degree lordotic core option in 98% of cases. This strong surgeon preference reinforces the clinical importance of restoring alignment in addition to preserving motion. Before receiving U.S. approval, the Synergy Disc (search) had been used for more than 10 years across more than 10 countries and implanted in thousands of patients, providing a substantial international clinical experience base.
"Reaching 100 U.S. cases within 100 days of our first commercial procedure reflects the strong early adoption of our technology and the growing demand among surgeons for cervical disc replacement solutions designed to support both motion and alignment," said Troy Wahlenmaier, Chief Commercial Officer of Synergy Spine Solutions (search). "Our focus remains on scaling thoughtfully — supporting surgeons throughout the rollout while expanding access to a technology backed by more than a decade of international clinical experience."
The device is built from time-tested orthopedic materials chosen to support reliable procedures, clear MRI-compatible postoperative imaging, and broader access for patients. Developed in close collaboration with spine surgeons, the Synergy Disc (search) reflects a patient-first philosophy prioritizing surgical consistency and helping patients reclaim their quality of life.